semaglutide update Novo Nordisk's shortage officially concludes in the US, spelling major threat for weight loss drug compounders Week 17 Ozempic/Semaglutide Update |

Neoplasms (except in cases of vitamin B12 deficiency and megaloblastic anemia)

GLP-1 medications were initially developed to treat diabetes but have recently gained widespread recognition for their significant effectiveness in promoting weight loss

Langlais P

At DKK288, the shares are just under the target price, reflecting the finely balanced risk profile Deutsche Bank sees for the stock.

Skip treatment if you have an active or recent cancer , uncontrolled diabetes , severe heart disease, untreated endocrine disorders, or if you are pregnant or breastfeeding

[3] [4] The appetite suppression is the primary mechanism behind its effectiveness for weight loss